Skip to main content

Nonprofit · EIN 04-3673104

PHELAN MCDERMID SYNDROME FOUNDATION

Tax-exempt · OSPREY, FL 34229

Financials

$1.1M$1.1M2023$1.3M$1.4M2024$1.2M$1.1M2025
Revenue Expenses · by fiscal year end
Financials of PHELAN MCDERMID SYNDROME FOUNDATION by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2025990$1,245,861$1,082,374$163,487$2,220,653$154,468$2,066,185
December 31, 2024990$1,306,884$1,437,564-$130,680$2,109,869$210,527$1,899,342
December 31, 2023990$1,062,761$1,098,819-$36,058$2,243,009$216,181$2,026,828
Financial details: 990 for the year ended December 31, 2025

Revenue

Contributions, gifts and grants
$1,060,585
of which government grants
$110,632
Program service revenue
$14,143
Investment income
$96,976
Net income from fundraising events
$73,622
Other revenue
$74,157

Expenses

Grants and similar amounts paid
$105,000
Compensation of officers, directors and key employees
$351,129
Other salaries and wages
$199,809
Salaries, compensation and benefits (total)
$608,197
Professional fundraising fees
$0
Occupancy
$8,100
Travel
$40,204
Program services (functional)
$709,067
Management and general (functional)
$174,572
Fundraising (functional)
$198,735

Balance sheet and other

Total assets, start of year
$2,109,869
Total assets, end of year
$2,220,653
Total liabilities, end of year
$154,468
Net assets, end of year
$2,066,185
Publicly traded securities
$401,144
Net assets without donor restrictions
$2,062,385
Net assets with donor restrictions
$3,800
Gross receipts
$1,245,861
Employees
12
Volunteers
50
Year formed
2002
State of legal domicile
FL

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2025, highest compensation first.

NameTitleHours / weekCompensationOther / benefits
Diane LinnehanChief Operating Officer/Co-interim CEO
Officer, Highest-paid employee
40$117,089$3,327
Lauren SchmittChief Science Officer
Officer, Highest-paid employee
40$108,138$3,228
Shira JohnsonChief Development Officer/Co-Interim CEO
Officer
40$54,382$1,631
Priscilla HackstadtChief Financial Officer
Officer
16$48,022$1,402
Rhonda BlumenthalChief Executive Officer
Officer
40$30,446$913
Denise CrodenPresident
Trustee or director, Officer
5$0$0
Ben HolocherVice President
Trustee or director, Officer
5$0$0
Lisa BrownSecretary
Trustee or director, Officer
5$0$0
Michael CentoTreasurer
Trustee or director, Officer
5$0$0
Catherine Valcourt-PearceDirector
Trustee or director
2$0$0
Rebecca BuchananDirector
Trustee or director
2$0$0
Eden RiveraDirector
Trustee or director
2$0$0
Dr Lori LeviDirector
Trustee or director
2$0$0
Heidi Grabenstatter PhDDirector
Trustee or director
2$0$0
990 for the year ended December 31, 2024: 10 people
NameTitleHours / weekCompensationOther / benefits
Rhonda BlumenthalChief Executive Officer
Officer, Key employee
40$122,244$3,809
Denise CrodenPresident
Trustee or director, Officer
5$0$0
Ben HolocherVice President
Trustee or director, Officer
5$0$0
Lisa BrownSecretary
Trustee or director, Officer
5$0$0
Michael CentoTreasurer
Trustee or director, Officer
5$0$0
Catherine Valcourt-PearceDirector
Trustee or director
5$0$0
Chardell BuchananDirector
Trustee or director
5$0$0
Eden RiveraDirector
Trustee or director
5$0$0
Dr Lori LeviDirector
Trustee or director
5$0$0
Heidi Grabenstatter PhDDirector
Trustee or director
5$0$0
990 for the year ended December 31, 2023: 9 people
NameTitleHours / weekCompensationOther / benefits
Rhonda BlumenthalChief Executive Officer
Officer, Key employee
40$116,269$3,488
Denise CrodenPresident
Trustee or director, Officer
5$0$0
Lisa BrownVice President
Trustee or director, Officer
5$0$0
Heidi GrabenstatterSecretary
Trustee or director, Officer
5$0$0
Chris JauchTreasurer
Trustee or director, Officer
5$0$0
Catherine Valcourt-PearceDirector
Trustee or director
5$0$0
Mike FrauncesDirector
Trustee or director
5$0$0
Eden RiveraDirector
Trustee or director
5$0$0
Alycia HalladayDirector
Trustee or director
5$0$0

Address and contacts

Address (IRS master file)
8 SORRENTO DR, OSPREY, FL 34229-9610
Principal officer (990 for 2025)
Priscilla Hackstadt, 8 Sorrento Drive, Osprey, FL 34229
Signed the 990
Priscilla Hackstadt, Chief Financial Officer
Phone
(941) 485-8000
Website
pmsf.org

Mission

The mission of the Phelan-McDermid Syndrome Foundation is to make today better and the future brighter for everyone living with Phelan-McDermid syndrome - from the moment of diagnosis to the delivery of treatments and cures.

990 for the year ended December 31, 2025

Program accomplishments

  • CONNECT (Family Support): The Organization (PMSF) connects with families from diagnosis throughout their life journey, providing essential support, knowledge, and skills to navigate the complexities of Phelan Mc-Dermid syndrome. In 2025, PMSF provided 2,400 connections through comprehensive support services, welcoming 300 new families into membership. Key initiatives included supporting 133 newly diagnosed families via the "First 100 Days" program, educating 250 caregivers and professionals through the "Pathways" video series, and facilitating 48 Caregiver Support Group sessions for 250 participants. These programs integrate mental health, social, and emotional well-being, while regional and international gatherings further empower our community to thrive.
    Expenses $192,052
  • CARE (Improving Medical Care): The Organization (PMSF) ensures that individuals with Phelan-McDermid syndrome have access to a robust community of specialists and evidence-based care. We bridge the gap between research and clinical practice by educating professionals, facilitating medical consultation, and expanding our specialized clinical infrastructure. In 2025, we strengthened this ecosystem by establishing our first 11 Phelan-McDermid Syndrome Clinics-including a new multidisciplinary center at Cincinnati Children's Hospital Medical Center-and launched initiatives to grow our Healthcare Provider (HCP) network. Our experts facilitated 22 neuropsychiatric consultation cases, 15 neuropsychiatric referrals, and 50 genetic counseling referrals. Additionally, we served as a primary medical hub, recording over 100,000 views on pmsf.org and overseeing 3,500 downloads of clinical and educational resource documents.
    Expenses $168,860
  • CURE (Driving Research Breakthroughs): The Organization (PMSF) accelerates scientific discovery by centering the patient experience in research, expanding our clinical data infrastructure, and providing critical funding. In 2025, our grant committee awarded the Shannon O'Boyle Memorial Grant to Dr. Jonathan Santoro (Children's Hospital of Los Angeles) to advance vital neuropsychiatric biomarker research. We expanded the PMSF DataHub to 1,500 consented participants and 1,400 curated genetic reports, creating an invaluable resource for pharmaceutical and clinical partners. Furthermore, we directly facilitated participation in the Developmental Synaptopathies Consortium natural history study by providing travel reimbursements to 24 families. Our commitment to global knowledge-sharing was underscored by the PMSF podcast, which experienced 500% growth and reached audiences in 30 countries.
    Expenses $348,155 · grants $100,000 · revenue $14,143

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026990 on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
04-3673104
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
2003
Accounting year ends
December
Files
Form 990 or 990-EZ
Category (NTEE)
Medical research (H80)
Assets (IRS master file)
$2,220,653
Income (IRS master file)
$1,245,861

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2025$1,245,861$1,082,374$2,220,653XML
990December 2024$1,306,884$1,437,564$2,109,869XML
990December 2023$1,062,761$1,098,819$2,243,009XML
990December 2022$853,648$715,263$2,113,920IRS
990December 2021–––IRS
990December 2020–––IRS
990December 2019–––IRS
990December 2018–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 04-3673104).

Questions about PHELAN MCDERMID SYNDROME FOUNDATION

What is the EIN of PHELAN MCDERMID SYNDROME FOUNDATION?
The employer identification number (EIN) of PHELAN MCDERMID SYNDROME FOUNDATION is 04-3673104.
Is PHELAN MCDERMID SYNDROME FOUNDATION tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2003.
Are donations to PHELAN MCDERMID SYNDROME FOUNDATION tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does PHELAN MCDERMID SYNDROME FOUNDATION file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of PHELAN MCDERMID SYNDROME FOUNDATION due?
The return for tax year 2026 (the year ending December 31, 2026) is due May 17, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
When did PHELAN MCDERMID SYNDROME FOUNDATION last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2025.
Who is the principal officer of PHELAN MCDERMID SYNDROME FOUNDATION?
The 990 for the year ended December 31, 2025 names Priscilla Hackstadt.
Who are the officers and directors of PHELAN MCDERMID SYNDROME FOUNDATION?
The 990 for the year ended December 31, 2025 lists 14 people; 5 received compensation from the organization, the highest $117,089 (Diane Linnehan, Chief Operating Officer/Co-interim CEO).
How much revenue does PHELAN MCDERMID SYNDROME FOUNDATION have?
On its 990 for the year ended December 31, 2025 it reported revenue of $1,245,861, expenses of $1,082,374 and total assets of $2,220,653 at year end.

Other nonprofits in OSPREY

All nonprofits in OSPREY · Florida · Medical research